SE0101854D0 - The use of a compound with a negatively charged domain of radicals for the treatment of restenosis - Google Patents
The use of a compound with a negatively charged domain of radicals for the treatment of restenosisInfo
- Publication number
- SE0101854D0 SE0101854D0 SE0101854A SE0101854A SE0101854D0 SE 0101854 D0 SE0101854 D0 SE 0101854D0 SE 0101854 A SE0101854 A SE 0101854A SE 0101854 A SE0101854 A SE 0101854A SE 0101854 D0 SE0101854 D0 SE 0101854D0
- Authority
- SE
- Sweden
- Prior art keywords
- negatively charged
- restenosis
- radicals
- compound
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
- A61K31/6615—Compounds having two or more esterified phosphorus acid groups, e.g. inositol triphosphate, phytic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7024—Esters of saccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Molecular Biology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
- Luminescent Compositions (AREA)
Priority Applications (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0101854A SE0101854L (sv) | 2001-05-28 | 2001-05-28 | Användning av en förening med en negativt laddad region av grupper för behandling av restenos. |
AT02733745T ATE415975T1 (de) | 2001-05-28 | 2002-05-28 | Verwendung einer verbindung mit einer negativ geladenen domäne von phosphor-enthaltenden radikalen für die behandlung von restenosis |
PCT/SE2002/001016 WO2002096436A1 (en) | 2001-05-28 | 2002-05-28 | The use of a compound with a negatively charged domain of radicals for the treatment of restenosis |
JP2002592945A JP2004532872A (ja) | 2001-05-28 | 2002-05-28 | 再狭窄の治療のためにラジカルの負に帯電されたドメインをもった化合物の使用 |
DK02733745T DK1390045T3 (da) | 2001-05-28 | 2002-05-28 | Anvendelse af en forbindelse med et negativt ladet domæne af phosphorholdige radikaler til behandling af restenose |
US10/478,962 US20040235799A1 (en) | 2001-05-28 | 2002-05-28 | Use of a compound with a negatively charged domain of radicals for the treatment of restenosis |
EP02733745A EP1390045B1 (en) | 2001-05-28 | 2002-05-28 | The use of a compound with a negatively charged domain of phosphorous-containing radicals for the treatment of restenosis |
DE60230134T DE60230134D1 (de) | 2001-05-28 | 2002-05-28 | Verwendung einer verbindung mit einer negativ geladenen domäne von phosphor-enthaltenden radikalen für die behandlung von restenosis |
ES02733745T ES2316568T3 (es) | 2001-05-28 | 2002-05-28 | Uso de un compuesto con un dominio cargado negativamente de radicales que contiene fosforo para el tratamiento de reestenosis. |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0101854A SE0101854L (sv) | 2001-05-28 | 2001-05-28 | Användning av en förening med en negativt laddad region av grupper för behandling av restenos. |
Publications (2)
Publication Number | Publication Date |
---|---|
SE0101854D0 true SE0101854D0 (sv) | 2001-05-28 |
SE0101854L SE0101854L (sv) | 2002-11-29 |
Family
ID=20284248
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE0101854A SE0101854L (sv) | 2001-05-28 | 2001-05-28 | Användning av en förening med en negativt laddad region av grupper för behandling av restenos. |
Country Status (9)
Country | Link |
---|---|
US (1) | US20040235799A1 (sv) |
EP (1) | EP1390045B1 (sv) |
JP (1) | JP2004532872A (sv) |
AT (1) | ATE415975T1 (sv) |
DE (1) | DE60230134D1 (sv) |
DK (1) | DK1390045T3 (sv) |
ES (1) | ES2316568T3 (sv) |
SE (1) | SE0101854L (sv) |
WO (1) | WO2002096436A1 (sv) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FI20021570A0 (sv) * | 2002-09-03 | 2002-09-03 | Gallen Kallela Siren Janne | Förbättrad konstruktion av en belagd kirurgisk stent |
US10159297B2 (en) * | 2013-05-21 | 2018-12-25 | Bradford C. Jamison | Patterned plexus of filaments, method of producing and articles containing patterned filaments |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5128332A (en) * | 1984-10-23 | 1992-07-07 | Perstorp Ab | Method of treating cardiovascular diseases using inositoltrisphosphate |
US5389620A (en) * | 1993-08-18 | 1995-02-14 | Banyu Pharmaceutical Co., Ltd. | Endothelin antagonistic heteroaromatic ring-fused cyclopentene derivatives |
US5753230A (en) * | 1994-03-18 | 1998-05-19 | The Scripps Research Institute | Methods and compositions useful for inhibition of angiogenesis |
IT1275935B1 (it) * | 1995-03-17 | 1997-10-24 | Chiesi Farma Spa | Derivato di aminotetralina per la terapia di malattie cardiovascolari |
US6846839B1 (en) * | 1995-06-07 | 2005-01-25 | Sugen, Inc. | Methods for treating diseases and disorders related to unregulated angiogenesis and/or vasculogenesis |
CA2166155C (en) * | 1995-12-27 | 2008-02-05 | Eva Anne Turley | Agents binding to hyaluronic acid binding domains and the use thereof |
US20040063790A1 (en) * | 1996-05-31 | 2004-04-01 | The Scripps Research Institute | Methods for inhibition of angiogenesis |
AUPO888497A0 (en) * | 1997-09-01 | 1997-09-25 | Australian National University, The | Use of sulfated oligosaccharides as inhibitors of cardiovascular disease |
US6896659B2 (en) * | 1998-02-06 | 2005-05-24 | Point Biomedical Corporation | Method for ultrasound triggered drug delivery using hollow microbubbles with controlled fragility |
US6685938B1 (en) * | 1998-05-29 | 2004-02-03 | The Scripps Research Institute | Methods and compositions useful for modulation of angiogenesis and vascular permeability using SRC or Yes tyrosine kinases |
US6028061A (en) * | 1998-06-18 | 2000-02-22 | Children's Medical Center Corp | Angiogenesis inhibitors and use thereof |
US6043259A (en) * | 1998-07-09 | 2000-03-28 | Medicure Inc. | Treatment of cardiovascular and related pathologies |
AU6409499A (en) * | 1998-10-01 | 2000-04-17 | Children's Medical Center Corporation | Method of treatment of cardiovascular injuries |
US6573096B1 (en) * | 2000-04-01 | 2003-06-03 | The Research Foundation At State University Of New York | Compositions and methods for inhibition of cancer invasion and angiogenesis |
US7019108B2 (en) * | 2001-06-01 | 2006-03-28 | University Of Southern California | Method and composition for inhibition of angiogenesis and tumor growth using compounds based on a sequence within MMP-2 |
WO2004096832A2 (en) * | 2003-04-29 | 2004-11-11 | Children's Medical Center Corporation | Novel antiangiogenic peptides |
JP3958309B2 (ja) * | 2004-08-23 | 2007-08-15 | 株式会社名機製作所 | 射出成形機 |
-
2001
- 2001-05-28 SE SE0101854A patent/SE0101854L/sv not_active Application Discontinuation
-
2002
- 2002-05-28 WO PCT/SE2002/001016 patent/WO2002096436A1/en active Application Filing
- 2002-05-28 DE DE60230134T patent/DE60230134D1/de not_active Expired - Lifetime
- 2002-05-28 JP JP2002592945A patent/JP2004532872A/ja active Pending
- 2002-05-28 DK DK02733745T patent/DK1390045T3/da active
- 2002-05-28 US US10/478,962 patent/US20040235799A1/en not_active Abandoned
- 2002-05-28 EP EP02733745A patent/EP1390045B1/en not_active Expired - Lifetime
- 2002-05-28 ES ES02733745T patent/ES2316568T3/es not_active Expired - Lifetime
- 2002-05-28 AT AT02733745T patent/ATE415975T1/de not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
JP2004532872A (ja) | 2004-10-28 |
ATE415975T1 (de) | 2008-12-15 |
DE60230134D1 (de) | 2009-01-15 |
DK1390045T3 (da) | 2009-02-23 |
SE0101854L (sv) | 2002-11-29 |
US20040235799A1 (en) | 2004-11-25 |
ES2316568T3 (es) | 2009-04-16 |
EP1390045A1 (en) | 2004-02-25 |
WO2002096436A1 (en) | 2002-12-05 |
EP1390045B1 (en) | 2008-12-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BG108268A (en) | Pyrazolopyrimidines as therapeutic agents | |
BG108269A (en) | Pyrazolopyrimidines as therapeutic agents | |
EA200101046A1 (ru) | Производные индигоидных бис-индолов | |
DE60112974D1 (en) | Carbolinderivate | |
DE60030741D1 (de) | Chinazoline verbindungen als heilmittel | |
CY1107852T1 (el) | Νεες χρησεις αμινοξικων αντισπασμωδικων για τη θεραπευτικη αγωγη της ημικρανιας | |
ATE408601T1 (de) | Fredericamycin-derivate | |
DE69907977D1 (de) | Pyrrolobenzodiazepine | |
GEP20084499B (en) | USE OF INTERFERON-ß FOR TREATMENT OF RENAL FAILURE | |
UA83233C2 (ru) | Замещенный 2-аминотетралин для лечения депрессии | |
DE60216233D1 (en) | Carbolinderivate | |
NO20032027D0 (no) | Effektive antitumorbehandlinger | |
NO307687B1 (no) | Anvendelse av riluzol ved fremstilling av medikamenter for behandling av neuro-AIDS | |
SE0301232D0 (sv) | Novel use | |
DK1390371T3 (da) | Oxazolo- og furopyrimidiner samt deres anvendelse i lægemidler mod tumorer | |
BRPI0409959A (pt) | uso de derivados de azetidinacarboxamida em terapia | |
SE9802208D0 (sv) | Novel compounds | |
UA83272C2 (uk) | Спосіб захисту від ефектів іонізуючого випромінювання за допомогою флагеліну | |
GB0416508D0 (en) | Therapeutic agents | |
PT1030667E (pt) | Utilizacao de mirtazapina para o fabrico de um medicamento para o tratamento de apenas do sono | |
SE9900070D0 (sv) | New use | |
BRPI0416289A (pt) | 4-anilino-3-quinolinacarbonitrilas para o tratamento de leucemia mielógeno crÈnica (cml) | |
CY1105317T1 (el) | Χρηση υποκατεστημενων ενωσεων 6-διμεθυλαμινομεθυλο-1-φαινυλο-κυκλοεξανιου για τη θepαπεια της ακρατειας ουρων | |
NZ528164A (en) | Use of flumazenil to produce a medicament for the treatment of cocaine dependency | |
EE200300129A (et) | Distamütsiini alfa-halogenoakrüloüülderivaadi kasutamine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NAV | Patent application has lapsed |